Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Draft Genome Sequences of Azole-Resistant and Azole-Susceptible Aspergillus turcosus Clinical Isolates Recovered from Bronchoalveolar Lavage Fluid Samples.

Parent-Michaud M, Dufresne PJ, Fournier É, Martineau C, Moreira S, Perkins V, de Repentigny L, Dufresne SF.

Microbiol Resour Announc. 2019 Jan 3;8(1). pii: e01446-18. doi: 10.1128/MRA.01446-18. eCollection 2019 Jan.

2.

Draft Genome Sequence of Azole-Resistant Aspergillus thermomutatus (Neosartorya pseudofischeri) Strain HMR-AF-39, Isolated from a Human Nasal Septum Abscess Aspirate.

Parent-Michaud M, Dufresne PJ, Fournier É, Martineau C, Moreira S, Perkins V, de Repentigny L, Dufresne SF.

Microbiol Resour Announc. 2019 Jan 3;8(1). pii: e01444-18. doi: 10.1128/MRA.01444-18. eCollection 2019 Jan.

3.

Early-Onset Invasive Candidiasis in Extremely Low Birth Weight Infants: Perinatal Acquisition Predicts Poor Outcome.

Barton M, Shen A, O'Brien K, Robinson JL, Davies HD, Simpson K, Asztalos E, Langley J, Le Saux N, Sauve R, Synnes A, Tan B, de Repentigny L, Rubin E, Hui C, Kovacs L, Yau YC, Richardson SE; Paediatric Investigators Collaborative Network on Infections in Canada (PICNIC).

Clin Infect Dis. 2017 Apr 1;64(7):921-927. doi: 10.1093/cid/cix001.

PMID:
28077516
4.

Oropharyngeal Candidiasis in HIV Infection: Analysis of Impaired Mucosal Immune Response to Candida albicans in Mice Expressing the HIV-1 Transgene.

de Repentigny L, Goupil M, Jolicoeur P.

Pathogens. 2015 Jun 23;4(2):406-21. doi: 10.3390/pathogens4020406. Review.

5.

Defective IL-17- and IL-22-dependent mucosal host response to Candida albicans determines susceptibility to oral candidiasis in mice expressing the HIV-1 transgene.

Goupil M, Cousineau-Côté V, Aumont F, Sénéchal S, Gaboury L, Hanna Z, Jolicoeur P, de Repentigny L.

BMC Immunol. 2014 Oct 26;15:49. doi: 10.1186/s12865-014-0049-9.

6.

Invasive candidiasis in low birth weight preterm infants: risk factors, clinical course and outcome in a prospective multicenter study of cases and their matched controls.

Barton M, O'Brien K, Robinson JL, Davies DH, Simpson K, Asztalos E, Langley JM, Le Saux N, Sauve R, Synnes A, Tan B, de Repentigny L, Rubin E, Hui C, Kovacs L, Richardson SE.

BMC Infect Dis. 2014 Jun 12;14:327. doi: 10.1186/1471-2334-14-327.

7.

AIDS-related mycoses: the way forward.

Brown GD, Meintjes G, Kolls JK, Gray C, Horsnell W; Working Group from the EMBO-AIDS Related Mycoses Workshop, Achan B, Alber G, Aloisi M, Armstrong-James D, Beale M, Bicanic T, Black J, Bohjanen P, Botes A, Boulware DR, Brown G, Bunjun R, Carr W, Casadevall A, Chang C, Chivero E, Corcoran C, Cross A, Dawood H, Day J, De Bernardis F, De Jager V, De Repentigny L, Denning D, Eschke M, Finkelman M, Govender N, Gow N, Graham L, Gryschek R, Hammond-Aryee K, Harrison T, Heard N, Hill M, Hoving JC, Janoff E, Jarvis J, Kayuni S, King K, Kolls J, Kullberg BJ, Lalloo DG, Letang E, Levitz S, Limper A, Longley N, Machiridza TR, Mahabeer Y, Martinsons N, Meiring S, Meya D, Miller R, Molloy S, Morris L, Mukaremera L, Musubire AK, Muzoora C, Nair A, Nakiwala Kimbowa J, Netea M, Nielsen K, O'hern J, Okurut S, Parker A, Patterson T, Pennap G, Perfect J, Prinsloo C, Rhein J, Rolfes MA, Samuel C, Schutz C, Scriven J, Sebolai OM, Sojane K, Sriruttan C, Stead D, Steyn A, Thawer NK, Thienemann F, Von Hohenberg M, Vreulink JM, Wessels J, Wood K, Yang YL.

Trends Microbiol. 2014 Mar;22(3):107-9. doi: 10.1016/j.tim.2013.12.008.

8.

Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans.

Melkoumov A, Goupil M, Louhichi F, Raymond M, de Repentigny L, Leclair G.

J Antimicrob Chemother. 2013 Sep;68(9):2099-105. doi: 10.1093/jac/dkt137. Epub 2013 Apr 25.

PMID:
23620465
9.

Altered immune response differentially enhances susceptibility to Cryptococcus neoformans and Cryptococcus gattii infection in mice expressing the HIV-1 transgene.

Leongson K, Cousineau-Côté V, Goupil M, Aumont F, Sénéchal S, Gaboury L, Jolicoeur P, Kronstad JW, de Repentigny L.

Infect Immun. 2013 Apr;81(4):1100-13. doi: 10.1128/IAI.01339-12. Epub 2013 Jan 22.

10.

A defect in ATP-citrate lyase links acetyl-CoA production, virulence factor elaboration and virulence in Cryptococcus neoformans.

Griffiths EJ, Hu G, Fries B, Caza M, Wang J, Gsponer J, Gates-Hollingsworth MA, Kozel TR, De Repentigny L, Kronstad JW.

Mol Microbiol. 2012 Dec;86(6):1404-23. doi: 10.1111/mmi.12065. Epub 2012 Nov 1.

11.

Characteristics and outcome of infants with candiduria in neonatal intensive care - a Paediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study.

Robinson JL, Davies HD, Barton M, O'Brien K, Simpson K, Asztalos E, Synnes A, Rubin E, Le Saux N, Hui C, Langley JM, Sauve R, de Repentigny L, Kovacs L, Tan B, Richardson SE.

BMC Infect Dis. 2009 Nov 23;9:183. doi: 10.1186/1471-2334-9-183.

12.

Selective expression of human immunodeficiency virus Nef in specific immune cell populations of transgenic mice is associated with distinct AIDS-like phenotypes.

Hanna Z, Priceputu E, Chrobak P, Hu C, Dugas V, Goupil M, Marquis M, de Repentigny L, Jolicoeur P.

J Virol. 2009 Oct;83(19):9743-58. doi: 10.1128/JVI.00125-09. Epub 2009 Jul 15.

13.

Macrophage-mediated responses to Candida albicans in mice expressing the human immunodeficiency virus type 1 transgene.

Goupil M, Trudelle EB, Dugas V, Racicot-Bergeron C, Aumont F, Sénéchal S, Hanna Z, Jolicoeur P, de Repentigny L.

Infect Immun. 2009 Sep;77(9):4136-49. doi: 10.1128/IAI.00453-09. Epub 2009 Jun 29.

14.

Fatal disseminated Trichosporon asahii infection in a child with acute lymphoblastic leukemia.

Thibeault R, Champagne M, de Repentigny L, Fournet JC, Tapiero B, Moghrabi A, Ovetchkine P.

Can J Infect Dis Med Microbiol. 2008 Mar;19(2):203-5.

15.

Oral mucosal cell response to Candida albicans in transgenic mice expressing HIV-1.

de Repentigny L, Lewandowski D, Aumont F, Hanna Z, Jolicoeur P.

Methods Mol Biol. 2009;470:359-68. doi: 10.1007/978-1-59745-204-5_25.

PMID:
19089395
16.

Fatal zygomycosis caused by Mucor indicus in a child with an implantable left ventricular assist device.

de Repentigny L, St-Germain G, Charest H, Kokta V, Vobecky S.

Pediatr Infect Dis J. 2008 Apr;27(4):365-9. doi: 10.1097/INF.0b013e3181634f2b. Review.

PMID:
18316980
17.

Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.

Anaissie EJ, Segal BH, Graybill JR, Arndt C, Perfect JR, Kleinberg M, Pappas P, Benjamin D, Rubin R, Aberg JA, Adderson EE, Adler-Shohet FC, Akan H, Akova M, Almyroudis NG, Alexander BD, Andes D, Arrieta A, Baddley JW, Barron MA, Belzberg H, Boucher HW, Boyce TG, Casadevall A, Chandrasekar PH, Cleary JD, Cordonnier C, Cornely OA, Cuenca-Estrella M, Daly JS, Daoura N, Denning DW, dePauw B, de Repentigny L, Dignani MC, Dismukes WE, Donnelly JP, Donowitz GR, Dupont B, Drusano G, Ellis M, Espinel-Ingroff A, Fishman JA, Fleming R, Forrest G, Ghannoum M, Goldman M, Grazziutti M, Greene JN, Greenberg RN, Gubbins PO, Hadley S, Herbrecht R, Hiemenz JW, Hope W, Hospenthal DR, Husain S, Ito JI, Jacobson RM, Johnson M, Keating MR, Kett DH, Knapp K, Kontoyiannis DP, Krcmery VC, Larsen R, Laverdiere M, Ljungman P, Lortholary O, Maertens J, Marriott D, Mattiuzzi G, McGinnis MR, Morris M, Nucci M, Odds FC, Pankey GA, Patterson T, Pfaller M, Razonable RR, Reboli AC, Rinaldi MG, Roberts GD, Rodriguez Tudela JL, Rotstein C, Ruhnke M, Schuster M, Shoham S, Sia IG, Siebel N, Silviera F, Singh N, Sobel J, Solomkin JS, Sorrell TC, Steinbach WJ, Temesgen Z, Tortorano A, Vartivarian S, VerWeij P, Viscoli C, Viviani MA, Walker RC, Wheat JL, Wiley J, Williamson P, Wingard JR, Yu VL, Zaoutis T.

Clin Infect Dis. 2006 Oct 15;43(8):1031-9. Epub 2006 Sep 13. No abstract available. Erratum in: Clin Infect Dis. 2007 Mar 15;44(6):894.

PMID:
16983616
18.

The nuclear GTPase Gsp1p can affect proper telomeric function through the Sir4 protein in Saccharomyces cerevisiae.

Clément M, Deshaies F, de Repentigny L, Belhumeur P.

Mol Microbiol. 2006 Oct;62(2):453-68. Epub 2006 Aug 31.

19.

Altered CD4+ T cell phenotype and function determine the susceptibility to mucosal candidiasis in transgenic mice expressing HIV-1.

Lewandowski D, Marquis M, Aumont F, Lussier-Morin AC, Raymond M, Sénéchal S, Hanna Z, Jolicoeur P, de Repentigny L.

J Immunol. 2006 Jul 1;177(1):479-91.

20.

CD8+ T cells but not polymorphonuclear leukocytes are required to limit chronic oral carriage of Candida albicans in transgenic mice expressing human immunodeficiency virus type 1.

Marquis M, Lewandowski D, Dugas V, Aumont F, Sénéchal S, Jolicoeur P, Hanna Z, de Repentigny L.

Infect Immun. 2006 Apr;74(4):2382-91.

21.

Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection.

de Repentigny L, Lewandowski D, Jolicoeur P.

Clin Microbiol Rev. 2004 Oct;17(4):729-59, table of contents. Review.

22.

Animal models in the analysis of Candida host-pathogen interactions.

de Repentigny L.

Curr Opin Microbiol. 2004 Aug;7(4):324-9. Review.

PMID:
15288620
23.

Effect of the echinocandin caspofungin on expression of Candida albicans secretory aspartyl proteinases and phospholipase in vitro.

Ripeau JS, Aumont F, Belhumeur P, Ostrosky-Zeichner L, Rex JH, de Repentigny L.

Antimicrob Agents Chemother. 2002 Sep;46(9):3096-100.

24.

Mucosal candidiasis in transgenic mice expressing human immunodeficiency virus type 1.

de Repentigny L, Aumont F, Ripeau JS, Fiorillo M, Kay DG, Hanna Z, Jolicoeur P.

J Infect Dis. 2002 Apr 15;185(8):1103-14. Epub 2002 Mar 21.

PMID:
11930320
25.

Evidence for differential expression of candida albicans virulence genes during oral infection in intact and human immunodeficiency virus type 1-transgenic mice.

Ripeau JS, Fiorillo M, Aumont F, Belhumeur P, de Repentigny L.

J Infect Dis. 2002 Apr 15;185(8):1094-102. Epub 2002 Mar 21.

PMID:
11930319
26.

The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis.

Perfect JR, Cox GM, Lee JY, Kauffman CA, de Repentigny L, Chapman SW, Morrison VA, Pappas P, Hiemenz JW, Stevens DA; Mycoses Study Group.

Clin Infect Dis. 2001 Dec 1;33(11):1824-33. Epub 2001 Oct 22.

PMID:
11692293
27.

Overexpression of Bud5p can suppress mutations in the Gsp1p guanine nucleotide exchange factor Prp20p in Saccharomyces cerevisiae.

Clément M, Lavallée F, Barbès-Morin G, de Repentigny L, Belhumeur P.

Mol Genet Genomics. 2001 Sep;266(1):20-7.

PMID:
11589573
28.

Molecular cloning of CaYRB1, the Candida albicans RanBP1/YRB1 homologue.

Clément M, Fournier H, Ouspenski II, de Repentigny L, Belhumeur P.

Yeast. 2001 Jul;18(10):915-22.

29.

Characterization of CaGSP1, the Candida albicans RAN/GSP1 homologue.

Clément M, Fournier H, de Repentigny L, Belhumeur P.

Gene. 2000 May 30;250(1-2):159-69.

PMID:
10854789
30.
31.

Overexpression of Candida albicans secretory aspartyl proteinase 2 and its expression in Saccharomyces cerevisiae do not augment virulence in mice.

Dubois N, Colina AR, Aumont F, Belhumeur P, de Repentigny L.

Microbiology. 1998 Aug;144 ( Pt 8):2299-310.

PMID:
9720053
32.

Isolation and characterization of the Candida albicans SEC4 gene.

Clément M, Fournier H, de Repentigny L, Belhumeur P.

Yeast. 1998 May;14(7):675-80.

33.

Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children.

de Repentigny L, Ratelle J, Leclerc JM, Cornu G, Sokal EM, Jacqmin P, De Beule K.

Antimicrob Agents Chemother. 1998 Feb;42(2):404-8.

34.

Oral carriage of Candida albicans in murine AIDS.

Deslauriers N, Côté L, Montplaisir S, de Repentigny L.

Infect Immun. 1997 Feb;65(2):661-7.

35.

Development of a method to detect secretory mucinolytic activity from Candida albicans.

Colina AR, Aumont F, Belhumeur P, de Repentigny L.

J Med Vet Mycol. 1996 Nov-Dec;34(6):401-6.

PMID:
8971629
36.

Evidence for degradation of gastrointestinal mucin by Candida albicans secretory aspartyl proteinase.

Colina AR, Aumont F, Deslauriers N, Belhumeur P, de Repentigny L.

Infect Immun. 1996 Nov;64(11):4514-9.

38.

Ketoconazole and itraconazole susceptibility of Candida albicans isolated from patients infected with HIV.

St-Germain G, Dion C, Espinel-Ingroff A, Ratelle J, de Repentigny L.

J Antimicrob Chemother. 1995 Jul;36(1):109-18.

PMID:
8537258
39.

Lack of involvement of nitric oxide in killing of Aspergillus fumigatus conidia by pulmonary alveolar macrophages.

Michaliszyn E, Sénéchal S, Martel P, de Repentigny L.

Infect Immun. 1995 May;63(5):2075-8.

40.

Immunodiagnosis of invasive fungal infections.

De Repentigny L, Kaufman L, Cole GT, Kruse D, Latgé JP, Matthews RC.

J Med Vet Mycol. 1994;32 Suppl 1:239-52. Review. No abstract available.

PMID:
7722790
41.

Acquired immunity in experimental murine aspergillosis is mediated by macrophages.

de Repentigny L, Petitbois S, Boushira M, Michaliszyn E, Sénéchal S, Gendron N, Montplaisir S.

Infect Immun. 1993 Sep;61(9):3791-802.

42.

Application of biotyping and DNA typing of Candida albicans to the epidemiology of recurrent vulvovaginal candidiasis.

Mercure S, Poirier S, Lemay G, Auger P, Montplaisir S, de Repentigny L.

J Infect Dis. 1993 Aug;168(2):502-7.

PMID:
8101553
43.
44.

Graft-related endocarditis caused by Neosartorya fischeri var. spinosa.

Summerbell RC, de Repentigny L, Chartrand C, St Germain G.

J Clin Microbiol. 1992 Jun;30(6):1580-2.

45.

Serodiagnosis of candidiasis, aspergillosis, and cryptococcosis.

de Repentigny L.

Clin Infect Dis. 1992 Mar;14 Suppl 1:S11-22. Review.

PMID:
1562681
46.

Immunoblot analyses of the serologic response to Aspergillus fumigatus antigens in experimental invasive aspergillosis.

de Repentigny L, Kilanowski E, Pedneault L, Boushira M.

J Infect Dis. 1991 Jun;163(6):1305-11.

PMID:
2037796
47.

Production and characterization of monoclonal antibodies to cell wall antigens of Aspergillus fumigatus.

Ste-Marie L, Sénéchal S, Boushira M, Garzon S, Strykowski H, Pedneault L, de Repentigny L.

Infect Immun. 1990 Jul;58(7):2105-14.

48.
49.

Serological techniques for diagnosis of fungal infection.

de Repentigny L.

Eur J Clin Microbiol Infect Dis. 1989 Apr;8(4):362-75. Review.

PMID:
2497015
50.

Circulating antigens in systemic fungal diseases.

de Repentigny L.

Immunol Ser. 1989;47:471-84. Review. No abstract available.

PMID:
2490087

Supplemental Content

Loading ...
Support Center